Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Exploratory Research in Clinical and Social Pharmacy|September 11, 2023
Strengthening pill press control to combat fentanyl: Legislative and law enforcement imperativesNicholas LassiJournal of Personality|March 18, 2024
Extraversion and low introversion more equivalent to high introversion in depression during COVID-19Nicholas LassiHealthcare (Basel, Switzerland)|April 12, 2025
The Evolving Role of Grit: Shifts in Depression Risk Among High- and Low-Grit Individuals During COVID-19Nicholas LassiExploratory Research in Clinical and Social Pharmacy|February 6, 2024
Delayed and unmet prescription drug access linked to elevated anxiety symptoms during COVID-19: Retrospective findings from the NLSY79 child and young adult cohortNicholas LassiFrontiers in Public Health|October 31, 2022
Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?Chao Wang, Nicholas LassiDrug and Alcohol Review|June 12, 2026
Etomidate-Adulterated Vaping: Fragmented Global Drug Control and Public Health RisksNicholas Lassi, Su JiangHealthcare (Basel, Switzerland)|February 13, 2025
The Legal and Ethical Dimensions of Hospital Visitation Bans in the COVID-19 EraNicholas Lassi, Su Jiang, Yu DuInternational Journal of Environmental Research and Public Health|February 25, 2022
The Evolving Regulatory Landscape for Fentanyl: China, India, and Global Drug GovernanceChao Wang, Nicholas Lassi, Xiaohan Zhang, et al.Frontiers in Public Health|September 29, 2025
A decade of China's health silk road: policy review for global health governance and SDG partnershipsChao Wang, Shimin Huang, Nicholas Lassi, et al.Healthcare (Basel, Switzerland)|October 27, 2022
Privacy Protection in Using Artificial Intelligence for Healthcare: Chinese Regulation in Comparative PerspectiveChao Wang, Jieyu Zhang, Nicholas Lassi, et al.Pageof 1